DYNC1I1 — Cytoplasmic Dynein 1 Intermediate Chain 1

dync1i1
:---	:---
**Gene Symbol**	DYNC1I1
**Full Name**	Cytoplasmic Dynein 1 Intermediate Chain 1
**Chromosomal Location**	7p21.1
**NCBI Gene ID**	[1780](https://www.ncbi.nlm.nih.gov/gene/1780)
**OMIM**	[617305](https://www.omim.org/entry/617305)
**Ensembl ID**	ENSG00000111595
**UniProt ID**	[Q13418](https://www.uniprot.org/uniprot/Q13418)
**Gene Type**	Protein coding
**Associated Diseases**	[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [ALS](/diseases/amyotrophic-lateral-sclerosis), [Charcot-Marie-Tooth](/diseases/charcot-marie-tooth-disease)

Overview

DYNC1I1 (Cytoplasmic Dynein 1 Intermediate Chain 1) encodes a critical subunit of the cytoplasmic dynein-1 motor complex, the primary molecular motor responsible for retrograde axonal transport in neurons. The dynein complex moves cargo along microtubules toward the minus end, transporting materials from distal synapses back to the cell body. This function is essential for neuronal health, synaptic maintenance, and the clearance of pathological protein aggregates.

Gene Information

Molecular Structure and Function

Dynein Complex Architecture

Cytoplasmic dynein-1 is a large (~1.5 MDa) multisubunit motor complex composed of multiple heavy chains, intermediate chains, light intermediate chains, and light chains. DYNC1I1 encodes an intermediate chain (IC) subunit that plays a critical structural and regulatory role within the complex.

The dynein intermediate chain (IC) serves multiple essential functions:

1. Structural scaffold: ICs form the base of the dynein complex, anchoring the heavy chains that contain the motor domains

2. Cargo binding: Intermediate chains interact with cargo adaptors that link dynein to specific cellular cargoes

3. Regulatory function: IC phosphorylation state modulates dynein activity and cargo selection

4. Complex assembly: ICs are essential for proper assembly and stability of the entire dynein complex

Microtubule-Based Transport

Dynein moves toward the minus end of microtubules, which in neurons corresponds to the direction toward the cell body. This “retrograde” transport is essential for:

• Moving signaling endosomes from synapses to the soma

• Transporting synaptic vesicles and presynaptic components

• Retrograde trafficking of neurotrophic factors

• Clearance of misfolded proteins and aggregates

• Organelle positioning and distribution

Normal Function in Neurons

Retrograde Axonal Transport

The primary physiological function of DYNC1I1-containing dynein is retrograde axonal transport. This process is critical for maintaining neuronal connectivity and health:

Signaling Endosome Trafficking: Retrograde transport of signaling endosomes carrying neurotrophic signals (e.g., NGF, BDNF) from the synapse to the cell body is essential for neuronal survival signaling. Dynein-mediated transport ensures these signaling platforms reach the nucleus to activate transcription programs essential for neuronal health.

Synaptic Maintenance: Dynein transports synaptic components back to the cell body for recycling, repair, or degradation. This includes synaptic vesicle components, active zone proteins, and postsynaptic receptors.

Aggregate Clearance: In healthy neurons, dynein helps transport misfolded proteins and small aggregates toward the cell body where they can be delivered to the autophagy-lysosome system for degradation. This is a critical quality control mechanism.

Cellular Localization

DYNC1I1 is expressed throughout the nervous system with highest expression in:

• Hippocampus — particularly CA1-CA3 pyramidal neurons

• Cerebral cortex — layer 5 pyramidal neurons

• Cerebellum — Purkinje cells and granule cells

• Substantia nigra — dopaminergic neurons

• Spinal cord motor neurons

Disease Associations

Alzheimer’s Disease

DYNC1I1 dysfunction is strongly implicated in Alzheimer’s disease pathogenesis. Multiple mechanisms contribute:

Transport Deficits: In AD, dynein function is impaired, leading to retrograde transport deficits. This compromises the delivery of signaling endosomes and reduces clearance of toxic species from distal axons. Studies of AD postmortem brain show significantly altered DYNC1I1 expression patterns, with changes correlating with disease severity.

Amyloid-beta Impact: Amyloid-beta oligomers directly impair dynein function, creating a vicious cycle where Aβ disrupts transport, leading to further accumulation of toxic species. The dynein complex appears particularly vulnerable to oxidative damage in AD.

Tau Pathology: Hyperphosphorylated tau disrupts microtubule-based transport by altering microtubule stability and disrupting dynein-cargo interactions. DYNC1I1 dysfunction exacerbates tau pathology propagation by impairing the transport of tau-containing vesicles.

Parkinson’s Disease

In PD, DYNC1I1 plays several important roles:

Alpha-synuclein Transport: Dynein is involved in the intracellular trafficking of alpha-synuclein. Dysregulated transport may contribute to the spread of synuclein pathology.

Mitochondrial Quality Control: Dynein-mediated transport of damaged mitochondria toward the cell body for mitophagy is impaired in PD. This contributes to mitochondrial dysfunction.

Lysosomal Trafficking: The delivery of endolysosomal cargoes to the soma is dynein-dependent and compromised in PD models.

Amyotrophic Lateral Sclerosis (ALS)

DYNC1I1 and dynein function are central to ALS pathogenesis:

Axonal Transport Defects: Dynein-mediated transport deficits are an early feature in ALS, preceding clinical symptoms in mouse models.

Dynein Mutations: While DYNC1I1 itself is not a major ALS gene, mutations in other dynein subunits (particularly DYNC1H1) cause ALS-like phenotypes.

Aggregate Transport: The transport of TDP-43 and SOD1 aggregates is dynein-dependent, and impaired transport contributes to the accumulation of these pathological species.

Charcot-Marie-Tooth Disease

DYNC1I1 and other dynein components are directly linked to peripheral neuropathy:

Direct Mutations: Mutations in DYNC1I1 and related dynein components cause autosomal dominant Charcot-Marie-Tooth disease type 2.

Axonal Transport Failure: The primary mechanism is impaired axonal transport, leading to distal axonal degeneration.

Motor and Sensory Deficits: Patients present with progressive distal muscle weakness, atrophy, and sensory loss.

Mechanisms of Dysfunction

Transcriptional Changes

Multiple studies have documented altered DYNC1I1 expression in neurodegenerative disease:

• Downregulation of DYNC1I1 in AD hippocampal tissue

• Differential splicing producing truncated isoforms in disease states

• Epigenetic dysregulation affecting transcription

Post-translational Modifications

DYNC1I1 function is modulated by:

• Phosphorylation: Alters cargo binding and motor activity

• Oxidation: Oxidative stress in neurodegeneration impairs dynein function

• Proteolytic cleavage: Disease-associated proteases can cleave dynein subunits

Cargo Adaptor Dysfunction

The link between dynein and cargo is mediated by adaptor proteins. Many of these adaptors are themselves altered in neurodegeneration, contributing to transport deficits.

Therapeutic Implications

Targeting Dynein Function

Therapeutic strategies targeting dynein-mediated transport include:

1. Small molecule modulators: Compounds that enhance dynein motor activity or cargo binding

2. Gene therapy: Viral delivery of wild-type DYNC1I1 to restore function

3. Adaptor targeting: Modulating cargo-dynein interactions

4. Microtubule stabilization: Enhancing the tracks on which dynein moves

Challenges

• BBB penetration: Therapeutic agents must cross the blood-brain barrier

• Timing: Intervention likely most effective pre-symptomatically

• Dose optimization: Over-activation could have toxic effects

Research Directions

Current research areas include:

• High-throughput screening for dynein-modulating compounds

• Understanding the relationship between DYNC1I1 genetic variants and disease risk

• Developing viral vectors for gene delivery

• Biomarker development for dynein dysfunction

See Also

• Axonal Transport Mechanisms

• Synaptic Dysfunction in AD

• Protein Aggregate Clearance

• Alzheimer’s Disease

• Parkinson’s Disease

• ALS

External Links

• NCBI Gene: DYNC1I1

• UniProt: Q13418

• Ensembl: ENSG00000111595

• OMIM: 617305